HEADER HYDROLASE/HYDROLASE INHIBITOR 06-JUN-96 1PAU TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE TITLE 2 ALDEHYDE INHIBITOR AC-DEVD-CHO COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CASPASE-3, CPP32, YAMA; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: APOPAIN; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: CASPASE-3, CPP32, YAMA; COMPND 11 EC: 3.4.22.-; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: ACE-ASP-GLU-VAL-ASJ; COMPND 15 CHAIN: C; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES KEYWDS CYSTEINE PROTEASE, CASPASE-3, APOPAIN, CPP32, YAMA, PROTEASE- KEYWDS 2 INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.ROTONDA,J.W.BECKER REVDAT 5 09-AUG-23 1PAU 1 LINK REVDAT 4 29-NOV-17 1PAU 1 HELIX REVDAT 3 13-JUL-11 1PAU 1 VERSN REVDAT 2 24-FEB-09 1PAU 1 VERSN REVDAT 1 07-JUL-97 1PAU 0 JRNL AUTH J.ROTONDA,D.W.NICHOLSON,K.M.FAZIL,M.GALLANT,Y.GAREAU, JRNL AUTH 2 M.LABELLE,E.P.PETERSON,D.M.RASPER,R.RUEL,J.P.VAILLANCOURT, JRNL AUTH 3 N.A.THORNBERRY,J.W.BECKER JRNL TITL THE THREE-DIMENSIONAL STRUCTURE OF APOPAIN/CPP32, A KEY JRNL TITL 2 MEDIATOR OF APOPTOSIS. JRNL REF NAT.STRUCT.BIOL. V. 3 619 1996 JRNL REFN ISSN 1072-8368 JRNL PMID 8673606 JRNL DOI 10.1038/NSB0796-619 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.W.NICHOLSON,A.ALI,N.A.THORNBERRY,J.P.VAILLANCOURT, REMARK 1 AUTH 2 C.K.DING,M.GALLANT,Y.GAREAU,P.R.GRIFFIN,M.LABELLE, REMARK 1 AUTH 3 Y.A.LAZEBNIK,N.A.MUNDAY,S.M.RAJU,M.E.SMULSON,T.T.YAMIN, REMARK 1 AUTH 4 V.L.YU,D.K.MILLER REMARK 1 TITL IDENTIFICATION AND INHIBITION OF THE ICE/CED-3 PROTEASE REMARK 1 TITL 2 NECESSARY FOR MAMMALIAN APOPTOSIS REMARK 1 REF NATURE V. 376 37 1995 REMARK 1 REFN ISSN 0028-0836 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 78.0 REMARK 3 NUMBER OF REFLECTIONS : 7987 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE-R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.600 REMARK 3 FREE R VALUE TEST SET COUNT : 845 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.59 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 35.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 321 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE : 0.3300 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 38 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1905 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 34 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.34 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.308 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.14 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.091 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : APOPAIN.PAR REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : APOPAIN.PRO REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THERE IS NO ELECTRON DENSITY FOR RESIDUES A 145 - A 149, REMARK 3 A 296 - A 297, B 310 - B 319, AND B 402, PRESUMABLY DUE TO REMARK 3 DISORDER. MASS SPECTROMETRY INDICATES THAT THESE RESIDUES REMARK 3 ARE PRESENT IN THE SPECIES CRYSTALLIZED. REMARK 4 REMARK 4 1PAU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000175574. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-95 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 5.0-8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SAINT REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8929 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 36.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.1 REMARK 200 DATA REDUNDANCY : 2.330 REMARK 200 R MERGE (I) : 0.06340 REMARK 200 R SYM (I) : 0.05550 REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.27 REMARK 200 R MERGE FOR SHELL (I) : 0.25700 REMARK 200 R SYM FOR SHELL (I) : 0.26200 REMARK 200 FOR SHELL : 2.590 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: PROTEIN COMPONENT OF INTERLEUKIN-1BETA CONVERTING REMARK 200 ENZYME (PDB ENTRY 1ICE) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP VAPOR DIFFUSION. 1.5 REMARK 280 MICROLITER DROPS OF PROTEIN:INHIBITOR SOLUTION (8.7 MG/ML IN 10 REMARK 280 MILLIMOLAR TRIS-HCL PH 8.5, 10 MILLIMOLAR DTT, 3 MILLIMOLAR REMARK 280 SODIUM AZIDE) WERE MIXED WITH AN EQUAL VOLUME OF RESERVOIR REMARK 280 BUFFER (7% PEG-6000 (W/W), 0.10 MOLAR SODIUM CITRATE PH 5.0, 10 REMARK 280 MILLIMOLAR DTT, 3 MILLIMOLAR SODIUM AZIDE) AND INCUBATED AT ROOM REMARK 280 TEMPERATURE, VAPOR DIFFUSION - HANGING DROP, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.90500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.31000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.39500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.90500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.31000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.39500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.90500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 42.31000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 48.39500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.90500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 42.31000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 48.39500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 33490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -177.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 69.81000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 169.24000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 69.81000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 169.24000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -83.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 69.81000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE INHIBITOR IS COVALENTLY CONNECTED TO CYS OF THE ENZYME TO FORM REMARK 400 A HEMITHIOKETAL. REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-ALDEHYDE IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-ALDEHYDE REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 145 REMARK 465 GLY A 146 REMARK 465 ILE A 147 REMARK 465 SER A 148 REMARK 465 LEU A 149 REMARK 465 THR A 296 REMARK 465 ASP A 297 REMARK 465 SER B 310 REMARK 465 GLY B 311 REMARK 465 VAL B 312 REMARK 465 ASP B 313 REMARK 465 ASP B 314 REMARK 465 ASP B 315 REMARK 465 MET B 316 REMARK 465 ALA B 317 REMARK 465 CYS B 318 REMARK 465 HIS B 319 REMARK 465 HIS B 402 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 236 -176.93 -177.47 REMARK 500 LYS B 363 -38.30 -143.41 REMARK 500 PHE B 400 42.08 -102.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: S1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: INHIBITOR BINDING SUB-SITE S1. REMARK 800 REMARK 800 SITE_IDENTIFIER: S2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: INHIBITOR BINDING SUB-SITE S2. REMARK 800 REMARK 800 SITE_IDENTIFIER: S3 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: INHIBITOR BINDING SUB-SITE S3. REMARK 800 REMARK 800 SITE_IDENTIFIER: S4 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: INHIBITOR BINDING SUB-SITE S4. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF ACE-ASP-GLU-VAL-ASA REMARK 999 REMARK 999 SEQUENCE REMARK 999 AMINO ACID RESIDUES ARE NUMBERED TO FACILITATE COMPARISON REMARK 999 WITH THE INTERLEUKIN 1-BETA CONVERTING ENZYME (ICE, PDB REMARK 999 ENTRY 1ICE). RESIDUES IN APOPAIN ARE ASSIGNED THE NUMBERS REMARK 999 OF THE HOMOLOGOUS RESIDUES IN THE ALIGNED THREE-DIMENSIONAL REMARK 999 STRUCTURE OF ICE. APOPAIN SEQUENCE NUMBERS ARE OMITTED REMARK 999 WHEN NO ICE-RELATED RESIDUE IS PRESENT IN APOPAIN, AND REMARK 999 APOPAIN-SPECIFIC INSERTIONS ARE INDICATED BY THE ADDITION REMARK 999 OF LETTERS TO THE ICE SEQUENCE NUMBERS. DBREF 1PAU A 145 297 UNP P42574 ICE3_HUMAN 29 175 DBREF 1PAU B 310 402 UNP P42574 ICE3_HUMAN 176 277 DBREF 1PAU C 501 505 PDB 1PAU 1PAU 501 505 SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 A 147 ILE GLU THR ASP SEQRES 1 B 102 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 B 102 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 B 102 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 B 102 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 B 102 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 B 102 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 B 102 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 B 102 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS SEQRES 1 C 5 ACE ASP GLU VAL ASJ HET ACE C 501 3 HET ASJ C 505 8 HETNAM ACE ACETYL GROUP HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID FORMUL 3 ACE C2 H4 O FORMUL 3 ASJ C4 H9 N O3 FORMUL 4 HOH *34(H2 O) HELIX 1 A THR A 182 ASN A 195 1 14 HELIX 2 B ARG A 208 LYS A 220 1 13 HELIX 3 C LEU A 258 PHE A 264 1 7 HELIX 4 D TRP B 348 ALA B 361 1 14 HELIX 5 E PHE B 366 GLU B 379A 1 15 SHEET 1 1 6 GLU A 199 ASN A 204 0 SHEET 2 1 6 GLU A 162 ASN A 169 1 O CYS A 165 N ARG A 201 SHEET 3 1 6 ARG A 227 LEU A 235 1 O VAL A 231 N ILE A 166 SHEET 4 1 6 LYS A 278 GLN A 283 1 O LEU A 279 N CYS A 232 SHEET 5 1 6 PHE B 327 TYR B 331 1 O LEU B 328 N PHE A 280 SHEET 6 1 6 CYS B 388 MET B 393 -1 O VAL B 390 N TYR B 329 SHEET 1 2 3 GLY B 346 SER B 347 0 SHEET 2 2 3 TRP B 340 ASN B 342 -1 O ASN B 342 N GLY B 346 SHEET 3 2 3 ASP C 502 VAL C 504 -1 O GLU C 503 N ARG B 341 SHEET 1 3 3 GLY A 238 GLU A 239 0 SHEET 2 3 3 ILE A 242 GLY A 245 -1 O ILE A 242 N GLU A 239 SHEET 3 3 3 GLY A 254 ASP A 257 -1 O VAL A 256 N ILE A 243 LINK SG CYS A 285 C ASJ C 505 1555 1555 1.77 LINK C ACE C 501 N ASP C 502 1555 1555 1.33 LINK C VAL C 504 N ASJ C 505 1555 1555 1.33 SITE 1 S1 10 ARG A 179 SER A 236 HIS A 237 GLY A 238 SITE 2 S1 10 GLN A 283 ALA A 284 CYS A 285 SER B 339 SITE 3 S1 10 TRP B 340 ARG B 341 SITE 1 S2 6 CYS A 285 TYR B 338 SER B 339 TRP B 340 SITE 2 S2 6 ARG B 341 PHE B 381H SITE 1 S3 6 SER A 178 ARG A 179 SER A 180 TRP B 340 SITE 2 S3 6 ARG B 341 SER B 343 SITE 1 S4 8 TRP B 340 ARG B 341 ASN B 342 GLY B 346 SITE 2 S4 8 SER B 347 TRP B 348 SER B 381A PHE B 381B SITE 1 AC1 15 SER A 175A ARG A 179 HIS A 237 GLN A 283 SITE 2 AC1 15 CYS A 285 TYR B 338 SER B 339 TRP B 340 SITE 3 AC1 15 ARG B 341 ASN B 342 SER B 343 SER B 381A SITE 4 AC1 15 PHE B 381B HOH B 626 HOH C 619 CRYST1 69.810 84.620 96.790 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014325 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011818 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010332 0.00000